MY

Mahendrasingh Yashawantsingh Parihar

Active Director Director DIN 11378208
DIN 11378208 First appointment Nov 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahendrasingh Yashawantsingh Parihar

Data last updated:

Mahendrasingh Yashawantsingh Parihar is a Director at Csn Cardiac Group Private Limited (since 2025).

DIN 11378208
Primary Designation Director
First Appointment 12 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Csn Cardiac Group Private Limited U86100MH2025PTC460742
Director12 Nov 20252025Active

Board colleagues of Mahendrasingh Yashawantsingh Parihar

NameDINCompanyDesignation
Dnyaneshwar Sanjab Cheke11378209Csn Cardiac Group Private LimitedDirector

Directorship timeline

Open interactive timeline →
Csn Cardiac Group Private Limited
Premium access

Shareholding and investment profile for Mahendrasingh Yashawantsingh Parihar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendrasingh Yashawantsingh Parihar

Mahendrasingh Yashawantsingh Parihar currently holds 1 directorship: Csn Cardiac Group Private Limited (Director, since 12 Nov 2025).

Mahendrasingh Yashawantsingh Parihar was first appointed on 12 Nov 2025 as Director at Csn Cardiac Group Private Limited.

The current boards of Mahendrasingh Yashawantsingh Parihar's companies include Dnyaneshwar Sanjab Cheke (Csn Cardiac Group Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available